Hepatitis C virus acquisition among Egyptians: Analysis of a 10-year surveillance of acute hepatitis C

Tropical Medicine and International Health

Volumn 20, Issue 1, 2015, Pages 89-97

  Mohsen, Amira ^a   Bernier, Adeline ^b   Lefouler, Lenaig ^b   Delarocque Astagneau, Elisabeth ^b   El Daly, Mai ^c,d,e   El Kafrawy, Sherif ^c,d,e   El Mango, Salwa ^f   Abdel Hamid, Mohamed ^d,g   Gadallah, Mohsen ^h   Esmat, Gamal ⁱ   Mohamed, Mostafa K ^h   Fontanet, Arnaud ^b,j  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b INSTITUT PASTEUR   (France)

^c MENOUFIA UNIVERSITY   (Egypt)

^d NATIONAL HEPATOLOGY AND TROPICAL MEDICINE RESEARCH INSTITUTE   (Egypt)

^e KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^f Alexandria Fever Hospital   (Egypt)

^g Minia University   (Egypt)

^h AIN SHAMS UNIVERSITY   (Egypt)

ⁱ CAIRO UNIVERSITY   (Egypt)

^j Bioinformatique et Chimie Moléculaire   (France)

more..

Author keywords

Acute hepatitis C; Egypt; Epidemiology; Risk factors

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN;

ACUTE HEPATITIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION; CASE CONTROL STUDY; CESAREAN SECTION; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG USE; EGYPTIAN; ENDOSCOPY; FEMALE; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEROCONVERSION; SEXUALITY; TOOTH EXTRACTION; ACUTE DISEASE; ADOLESCENT; AGED; ATTITUDE TO HEALTH; CLINICAL TRIAL; EGYPT; HEALTH; HEPACIVIRUS; MIDDLE AGED; MULTICENTER STUDY; QUESTIONNAIRE; SUBSTANCE-RELATED DISORDERS; TRANSMISSION; VIROLOGY; YOUNG ADULT;

HEPATITIS C VIRUS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; EGYPT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; URBAN HEALTH; YOUNG ADULT;

EID: 84913606035     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12410     Document Type: Article

References (32)

1. Abdel-Hamid M, Edelman DC, Highsmith WE & Constantine NT (1997) Optimization, assessment, and proposed use of a direct nested reverse transcription-polymerase chain reaction protocol for the detection of hepatitis C virus. Journal of Human Virology 1, 58-65.
2. Alter MJ (2007) Epidemiology of hepatitis C virus infection. World Journal of Gastroenterology 13, 2436-2441.
3. Arafa N, El Hoseiny M, Rekacewicz C et al. (2005) Changing patterns of hepatitis C virus spread in rural areas of Egypt. Journal of Hepatology 43, 418-424.
4. Carney K, Dhalla S, Aytaman A, Tenner CT & Francois F (2013) Association of tattooing and hepatitis C virus infection: A multicenter case-control study. Hepatology 57, 2117-2123.
5. Centers for Disease Control and Prevention (2002) Viral hepatitis and injection drug users. Available at http://www.cdc.gov/idu/hepatitis/viral_hep_drug_use.pdf.
6. Centers for Disease Control and Prevention (2012) Progress toward prevention and control of hepatitis C virus infection-Egypt, 2001-2012. Morbidity and Mortality Weekly Report 61, 545-549. Available at http://www.cdc.gov/mmwr/pdf/wk/mm6129.pdf.
7. Del Corno G & Civardi E (2006) Intrafamilial transmission of hepatitis B and C viruses in an Italian local health district. Annali di Igiene 18, 287-295.
8. El-Zanaty F & Way A (2009) Egypt Demographic and Health Survey 2008. Ministry of Health, El-Zanaty and Associates, and Macro International, Cairo. Available at http://www.measuredhs.com/pubs/pdf/fr220/fr220.pdf.
9. Fabris P, Fleming VM, Giordani MT & Barnes E (2008) Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection. Current Pharmaceutical Design 14, 1661-1665.
10. Guerra J, Garenne M, Mohamed MK & Fontanet A (2012) HCV burden of infection in Egypt: results from a nationwide survey. Journal of Viral Hepatitis 19, 560-567.
11. Habib M, Mohamed MK, Abdel-Aziz F et al. (2001) Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 33, 248-253.
12. Hajarizadeh B, Grebely J & Dore GJ (2012) Case definitions for acute hepatitis C virus infection: a systematic review. Journal of Hepatology 57, 1349-1360.
13. Hauri AM, Armstrong GL & Hutin YJ (2004) The global burden of disease attributable to contaminated injections given in health care settings. International Journal of STD and AIDS 15, 7-16.
14. Kandeel AM, Talaat M, Afifi SA et al. (2012) Case control study to identify risk factors for acute hepatitis C virus infection in Egypt. BMC Infectious Diseases 12, 294.
15. Lavanchy D (2011) Evolving epidemiology of hepatitis C virus. Clinical Microbiology & Infection 17, 107-115.
16. Magder LS, Fix AD, Mikhail NN et al. (2005) Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence data. International Journal of Epidemiology 34, 160-165.
17. Mariano A, Mele A, Tosti ME et al. (2004) Role of beauty treatment in the spread of parenterally transmitted hepatitis viruses in Italy. Journal of Medical Virology 74, 216-220.
18. Mostafa A, Taylor SM, El-Daly M et al. (2010) Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections. Liver International 30, 560-566.
19. Murray JM, Law MG, Gao Z & Kaldor JM (2003) The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users. International Journal of Epidemiology 32, 708-714.
20. Nelson PK, Mathers BM, Cowie B et al. (2011) Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 378, 571-583.
21. Njouom R, Lavoie M, Foupouapouognigni Y et al. (2011) Transmission of hepatitis C virus among spouses in Cameroon and the Central African Republic. Journal of Medical Virology 83, 2113-2118.
22. Paez Jimenez A, Mohamed MK, Eldin NS et al. (2009) Injection drug use is a risk factor for HCV infection in urban Egypt. PLoS One 4, e7193.
23. Paez Jimenez A, Sharaf Eldin N, Rimlinger F et al. (2010) HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt. Gut 59, 1554-1560.
24. Qureshi H, Arif A, Ahmed W & Alam SE (2007) HCV exposure in spouses of the index cases. Journal of the Pakistan Medical Association 57, 175-177.
25. Ramia S, Melhem NM & Kreidieh K (2012) Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population. Infection 40, 1-10.
26. Razzaghi E, Rahimi A, Hosseini M, Madani S & Chatterjee A (2000) Rapid situation assessment of drug abuse in Iran. Iranian Welfare Organization and UNDCP. Available at http://www.unrol.org/files/RSA2000SUMMARY%5B1%5D.pdf.
27. Soliman C, Rahman IA, Shawky S et al. (2010) HIV prevalence and risk behaviors of male injection drug users in Cairo, Egypt. AIDS 24 (Suppl 2), S33-S38.
28. Tahan V, Karaca C, Yildirim B et al. (2005) Sexual transmission of HCV between spouses. American Journal of Gastroenterology 100, 821-824.
29. Talaat M, El-Oun S, Kandeel A et al. (2003) Overview of injection practices in two governorates in Egypt. Tropical Medicine and International Health 8, 234-241.
30. Thursz M & Fontanet A (2013) HCV transmission in developed countries and resource-constrained areas. Nat Rev Gastroenterol Hepatol 11, 28-35 doi:10.1038/nrgastro.2013.179.
31. Tohme RA & Holmberg SD (2010) Is sexual contact a major mode of hepatitis C virus transmission? Hepatology 52, 1497-1505.
32. Yaphe S, Bozinoff N, Kyle R, Shivkumar S, Pai NP & Klein M (2012) Incidence of acute hepatitis C virus infection among men who have sex with men with and without HIV infection: a systematic review. Sexually Transmitted Infections 88, 558-564.